Multiple Assemblies exist for SMTL entry 5egu
FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-Butyl-8-(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-ylsulfanylmethyl)-7-ethyl-3,7-dihydropurine-2,6-dione; X-RAY DIFFRACTION 2.21 Å

	SMTL ID 5egu.1 Ligands 3-butyl-8-[(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)sulfanylmethyl]-7-ethyl-purine-2,6-dione; 1,2-ETHANEDIOL Polypeptides Bromodomain-containing protein 4 Oligo-state monomer
	SMTL ID 5egu.2 Ligands 3-butyl-8-[(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)sulfanylmethyl]-7-ethyl-purine-2,6-dione Polypeptides Bromodomain-containing protein 4 Oligo-state monomer
	SMTL ID 5egu.3 Ligands 3-butyl-8-[(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)sulfanylmethyl]-7-ethyl-purine-2,6-dione Polypeptides Bromodomain-containing protein 4 Oligo-state monomer
	SMTL ID 5egu.4 Ligands 3-butyl-8-[(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)sulfanylmethyl]-7-ethyl-purine-2,6-dione Polypeptides Bromodomain-containing protein 4 Oligo-state monomer